Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Autolus Therapeutics Sets U.S. HQ in Maryland, Will Create 170 Jobs

London-based Autolus Therapeutics announced plans to locate the company’s U.S. headquarters in Rockville, Maryland.

Read More »

Family behind Purdue Pharma pushed opioid marketing, Massachusetts says

Members of the wealthy Sackler family behind Purdue Pharma LP pushed the company to boost sales of OxyContin and other opioids even as questions emerged about the extent the drugmaker’s painkillers were being abused, Massachusetts’ attorney general alleged.

Read More »

AstraZeneca Lays off 210 in Colorado

AstraZeneca filed a Worker Readjustment and Retraining Notification Act (WARN) notice with the State of Colorado, indicating plans to lay off 210 people in Boulder and Longmont.

Read More »

Connecticut Judge Dismisses Opioid Drug Lawsuits

A judge dismissed lawsuits filed by 37 different municipal governments pertaining to opioid drugmakers being sued in the state of Connecticut.

Read More »

Sen. Sanders, Rep. Cummings to introduce bill to lower U.S. drug prices

U.S. Senator Bernie Sanders and Representative Elijah Cummings plan to introduce legislation aimed at lowering the cost of prescription drugs for U.S. consumers.

Read More »

Pfizer to shut two manufacturing plants in India

U.S. drugmaker Pfizer Inc. said the company was shutting down two manufacturing plants in India that make generic injectables such as penicillin in response to falling demand.

Read More »

Akorn gets FDA warning letter for Illinois plant

Akorn Inc. received a warning letter from the U.S. Food and Drug Administration following an inspection of the generic drugmaker’s Decatur, Illinois manufacturing plant during 2018.

Read More »

New York City launches $100 million universal health insurance program

New York City launched a $100 million health insurance program to cover 600,000 uninsured residents, including those unable to afford coverage and those living in the United States illegally.

Read More »

Gilead Inks $785 Million Deal With Yuhan

Gilead Sciences Inc. is acquiring the global rights to develop and commercialize novel small molecules against two targets from South Korea-based Yuhan Corporation.

Read More »

Johns Hopkins, Bristol-Myers must face $1 billion syphilis infections lawsuit

A federal judge in Maryland said The Johns Hopkins University, Bristol-Myers Squibb Co. and the Rockefeller Foundation must face a $1 billion lawsuit over their roles in a 1940s U.S. government experiment that infected hundreds of Guatemalans with syphilis.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!

Subscribe

Ad Right Bottom